New Haven, CT (January 12, 2025) – Yale New Haven Hospital (YNHH) has been selected as a recipient of the prestigious Special Pathogen Treatment and Network Development (STAND) Award, receiving a $500,000 grant to enhance the hospital’s capacity to care for patients with high-consequence infectious diseases.
Administered by the National Emerging Special Pathogens Training and Education Center (NETEC) in partnership with the Administration for Strategic Preparedness and Response (ASPR), the STAND Award is part of a strategic national effort to bolster preparedness among Level 2 Special Pathogen Treatment Centers. This initiative supports personnel training, simulation exercises, specialized equipment, laboratory capacity, infection prevention and control improvements and emergency coordination protocols.
“Receiving the STAND Award is a testament to Yale New Haven Hospital’s unwavering commitment to patient safety and public health,” said Katherine Heilpern, MD, president, Yale New Haven Hospital (YNHH). “This funding will strengthen our infrastructure and ensure our frontline teams can respond rapidly and effectively to outbreaks of dangerous pathogens. Nationally, 54 hospitals received this award, and it’s an honor to be part of this elite group working to advance preparedness and readiness.”
By integrating YNHH into the enhanced national network of Level 2 Special Pathogen Treatment Centers, the STAND initiative aims to ensure communities have access to high-quality, timely care during public health emergencies.
“This grant empowers us to build on our existing infectious disease expertise and collaboration with regional public health partners,” said David Calfee, MD, chief epidemiologist, Yale New Haven Health (YNHHS). “It enables critical advancements in protocols, training and patient care practices – ultimately strengthening our ability to protect both patients and our community.”
YNHH is proud to partner with NETEC, ASPR and public health agencies to advance a safer, more resilient healthcare system equipped to handle future infectious disease threats.
Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org
